111 (YI) Operating Margin (2017 - 2025)
111's (YI) quarterly Operating Margin came in at 0.01% in Q4 2025, up 18.0% year-on-year from 0.01% in Q4 2024, and up 85.02% quarter-over-quarter from 0.08% in Q3 2025.
111 (YI) Operating Margin (2017 - 2025) Analysis & Trends
111 has disclosed Operating Margin across 9 years of filings, most recently posting 0.01% for Q4 2025.
- Operating Margin for Q4 2025 came in at 0.01%, up 18.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.02% (down 3.0% YoY), and the FY2025 annual result was 0.02%, down 3.0% from the prior year.
- Operating Margin came in at 0.01% for Q4 2025 at 111, up from 0.08% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 0.11% in Q1 2024 to a low of 6.68% in Q1 2021.
- The 5-year median for Operating Margin is 0.89% (2023), against an average of 1.91%.
- Across the five-year window, Operating Margin surged 545 bps in 2021 and slumped 259 bps in 2022, its largest moves.
- 111's Operating Margin stood at 0.03% in 2021, then plunged by 10003 bps to 2.61% in 2022, then slumped by 92 bps to 5.03% in 2023, then surged by 96 bps to 0.19% in 2024, then jumped by 94 bps to 0.01% in 2025.
- The last three Operating Margin figures came in at 0.01% (Q4 2025), 0.08% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 2.23% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 1.46% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 0.84% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 5.40% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 2.73% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -41.35% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -0.01% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -12.18% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.08% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | -0.19% |
| Sep 30, 2024 | 0.07% |
| Jun 30, 2024 | 0.10% |
| Mar 31, 2024 | 0.11% |
| Dec 31, 2023 | -5.03% |
| Sep 30, 2023 | -2.19% |
| Jun 30, 2023 | -1.19% |
| Mar 31, 2023 | -0.59% |
| Dec 31, 2022 | -2.61% |
| Sep 30, 2022 | -2.41% |
| Jun 30, 2022 | -2.63% |
| Mar 31, 2022 | -3.42% |
| Dec 31, 2021 | -0.03% |
| Sep 30, 2021 | -5.24% |
| Jun 30, 2021 | -6.24% |
| Mar 31, 2021 | -6.68% |